The Latest Breaking News from National Medical Products Administration

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Pfizer’s (NYSE:PFE) lead drug GBS6 or PF-06760805 for the prevention of invasive GBS disease due to the vaccine serotypes in newborns and young infants by active immunization of their mothers during pregnancy. Pfizer shares traded in a…

Benzinga · Sep 7, 2022

China Approves Five COVID-19 Antigen Kits for Self-testing

China has granted approval to five COVID-19 antigen kits made by local companies to be used for self-testing, state broadcaster CCTV said on Saturday, as it tweaks its testing regime that has been pressured by Omicron. China's National Medical Products Administration (NMPA) published a notice on Friday saying Beijing Huaketai…

Asharq Al-Awsat · Mar 12, 2022

Sellas Life Sciences Shares Jump As China Approves Galinpepimut IND For Blood Cancer

China's National Medical Products Administration (NMPA) 

Benzinga · Jan 27, 2022